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Background: We have previously reported that dephnetin is therapeutically effective in the treatment of
rheumatoid arthritis (RA) in collagen-induced arthritis (CIA) rat model. However, the molecular mechanism and the
effect of daphnetin on demethylating proapoptotic genes in the synovial cells remains further clarified. This study
may provide a deeper insight into the medicinal application of daphnetin as a treatment for RA.
Methods: (1) The proliferation inhibition of CIA rat synovial cells was determined by an MTT (3-(4,5)-dimethylthiahiazo
(-z-y1)-3,5-di-phenyterazoliumromide) assay; (2) Methylation specific PCR (MSP) was used to measure the methylation of
the proapoptotic genes DR3 (death receptor 3), PDCD5 (programmed cell death 5), FasL and p53; (3) Real time-PCR
was performed to determine the mRNA expression of DR3, PDCD5, FasL, p53 and DNA methyltransferases (DNMTs)
DNMT1, DNMT3a and DNMT3b; (4) Flow cytometry was applied to detect the protein expression of the DR3, PDCD5,
FasL and p53; (5) The apoptotic rate of synovial cells was assessed by flow cytometry with Annexin V and propidium
iodide (PI); (6) Scanning electron microscopy (SEM) and transmission electron microscopy (TEM) were used to observe
the changes of CIA rat synovial cell structure.
Results: (1) In the range of 1.25 μg/mL to 40 μg/mL, daphnetin and 5-aza-dc had a dose-dependent and time-
dependent degree of inhibition to the CIA rat synovial cells. (2) Daphnetin and 5-aza-dc had a demethylating role on
the proapoptotic genes DR3, PDCD5, FasL and p53 of CIA rat synovial cells. (3) Daphnetin and 5-aza-dc decreased the
gene expression of methyltransferases DNMT1, DNMT3a and DNMT3b, and increased expression of proapoptotic genes
DR3, PDCD5, FasL and p53, which translated into an increased protein expression of DR3, PDCD5, FasL and p53.
(4) Daphnetin and 5-aza-dc changed the structure of CIA rat synovial cells to show apoptotic changes and increased
the rate of apoptosis.
Conclusions: Daphnetin can reduce the expression of DNMT1, DNMT3a and DNMT3b, which could result in the
proapoptotic genes DR3, PDCD5, FasL and p53 being demethylated. Therefore, daphnetin can increase proapoptotic
gene and protein expression resulting in structural apoptotic changes and an increase in early and late CIA rat synovial
cell apoptosis.
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Rheumatoid arthritis (RA) is a common systemic auto-
immune disease which is characterized by chronic in-
flammation of the joints, hyperplasia of synovial cells and
progressive destruction of cartilage and bone, leading to
joint deformity, dysfunction, and varying degrees of dis-
ability. According to the statistics, RA is affecting approxi-
mately 1% of the population [1]. Presently, drugs used in
the treatment of RA are mainly derived from Western and
Chinese medicine. However, since traditional Chinese
medicine usually reduces the side effects of Western medi-
cine and reduce disease recurrence rate, it is more promis-
ing to look for an effective drug derived from traditional
Chinese medicine or active components of Chinese medi-
cine for RA treatment and to discuss their mechanisms of
resistance. Daphnetin (7, 8-dihydroxycoumarin) extracted
from Daphne odora Var. Marginata (D. marginata) has
been used to treat various autoimmune diseases including
rheumatoid arthritis [2]. Our preliminary studies also found
daphnetin could augment Th17 cells and inhibit Treg cells
to reduce the swelling and inflammation in the feet of
CIA rats, which finally relieved articular cartilage de-
generation [3,4].
The pathogenesis of RA is not completely understood,
yet hyperplasia of the synovial cell is considered to be one
of the main factors towards the development of RA [5].
Apoptosis plays a pivotal role in tissue homoeostasis both
under physiological and pathological conditions, and some
characteristic changes in the composition and structure of
the inflamed synovial membrane in RA are linked to a
lowered apoptotic response of synovial cells [6]. RA syn-
ovial fibroblasts (RASFs) are versatile cells with the poten-
tial to activate an array of genes that are able to initiate
and propagate inflammation in RA-affected joints [7].
Studies found that rat joint synovial cell apoptosis is insuf-
ficient in type II collagen induced arthritis (CIA), inter-
nationally recognized as the most commonly used animal
model to research rheumatoid arthritis. However, there
are no relevant reports so far about RASFs’ ability to re-
duce apoptosis as a treatment for RA.
DNA methylation is the most studied and the most
important apparent genetic modification form. This
mainly occurs by the covalent bonding of a methyl
group on the fifth carbon atom in cytosine residues,
thus cytosine is modified to become 5-methyl-cytosine
(5 mC). Recent research shows that DNA methylation
can be affected by environmental factors, including pre-
natal smoking, drinking and environmental pollutants
[8-11]. RA pathogenesis is thought to be due to the
combination of genetic susceptibility, immune regula-
tion disorders and environmental factors [12-14]. As
well, other studies have reported mammalian gene func-
tion may be affected by apparent genetic modification
without changes to the DNA sequence, such is the casewith methylating DNA [15]. The complex etiopathology
of autoimmune rheumatic disorders has been attributed
to crosstalk between genetic predisposition and envir-
onmental factors, but recent advances in understanding
epigenetic mechanisms, especially DNA methylation in
the context of RA, may provide an important link re-
garding the pathogenesis of RA and may inspire devel-
opment of new targeted therapeutic approaches [16].
High DNA methylation can inactivate gene transcrip-
tion, leading to the development of disease. Luckily,
DNA methylation can be reversed through demethylat-
ing drugs such as the DNA methyltransferase inhibitor
5-aza-dc. In 2011, Francesca Meda [17] proposed that
epigenetics may be better able to explain autoimmune
disease, but research for epigenetic mechanisms in abnor-
mal gene expression remain confined to a small number of
laboratories. One such laboratory, run by Takami N, found
that the RA proapoptotic gene DR3 shows an abnormally
high methylation status, which may be the cause for the
lowered apoptotic response of synovial cells [18]. There-
fore, if we can prove there is a relationship between the ex-
pression of RA proapoptotic genes, abnormal apoptosis
and epigenetics, as well as understand the demethylating
molecular mechanism and effects of daphnetin on the
proapoptotic genes in the CIA rat synovial cells, we may
be provided with a new method and treatment for RA.
Materials and methods
Cell culture and treatment
The CIA rat synovial cells were purchased from the
American Type Culture Collection (ATCC, USA). They
were maintained in Dulbecco’s Modified Eagle Medium
(DMEM) (Gibco, USA) with 25 mM glucose, supple-
mented with 10% fetal bovine serum (FBS), nonessential
aminoacids, 100 IU/mL penicillin, 100 mg/mL strepto-
mycin and 2 mM glutamine. Cells were routinely cultured
in 75 cm2 tissue culture flasks and incubated in a humidi-
fied atmosphere of 5% CO2/95% air at 37°C. CIA rat syn-
ovial cells were treated with daphnetin (40 μg/mL), 5-aza-dc
(20 μM) or with the combination of them suspended in
complete DMEM medium over a time course of 72 h.
Cell viability assay
Determination of cell growth inhibition was performed
using a MTT assay. To investigate the effect of daphnetin
and 5-aza-dc on CIA rat synovial cell viability and prolifer-
ation, 5000 cells per well were grown in a 96-well microti-
ter plate in complete DMEM medium as control or
supplemented with Daphnetin(1.25 ~ 40 μg/mL) or 5-aza-
dc (1.25 ~ 20 μM) for 36, 48, 60 and 72 h. The cells were
then incubated with 20 μL MTT solution (5 mg/mL) for
4 h at 37°C. After this incubation period, purple formazan
salt crystals were formed. After careful removal of the
medium, 0.1 mL DMSO was added to each well. The
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a Universal Microplate Reader (EL800, BIO-TEK Instru-
ments Inc.). The effect of Daphnetin and 5-aza-dc on cell
growth inhibition was assessed as a reduction in percent
cell viability, where vehicle-treated cells were taken as
100% viable.
Methylation specific PCR
Genomic DNA was collected from cells by the TIANamp
Genomic DNA Kit (Tiangen biotech co., LTD., Beijing,
China). DNA was quantified with the use of an ultraviolet
spectrophotometer and analyzed by 1% agarose gel elec-
trophoresis after bisulphite modification according to the
EZ DNA Methylation-Gold™ Kit (ZYMO RESEARCH,
American). Methylation and demethylation primers were
designed with the online Methprimer software (Table 1)
and then synthesized by the Shanghai ShengGong bio-
logical engineering company. MSP was performed in the
ABI 7500 sequence detection system (Applied Biosystems).
Each MSP was conducted by adding 5 μL of RNase-free
ddH2O, 0.5 μL of forward and 0.5 μL of reverse primer of
methylation or demethylation (10 μM), 10 μL 2 × SuperReal
PreMix, 2 μL 50 × ROX Reference Dye, 2 μL cDNA tem-
plates in a total volume of 20 μL. The MSP protocol con-
sisted of 1 cycle at 95°C for 10 min, 40 cycles at 95°C for
10 s, 60°C for 20 s and 72°C for 31 s. MSP products
underwent 2% agarose gel electrophoresis (constant
voltage 120 v, 40 min) and an image was taken using a
gel image analysis system (BIO-RAD, Germany) under
ultraviolet light.
RNA Extraction and gene expression analysis
The expression of DR3, PDCD5, FasL, p53 and methyl-
transferases DNMT1, DNMT3a and DNMT3b in CIA rat
synovial cells was measured by real-time PCR. First, total
RNA was isolated from the cultured cells using the
RNeasy Micro Kit (Tiangen biotech co., LTD., Beijing,
China) according to the manufacturer’s procedure. One
microliter of total RNA was reverse-transcribed using a
1st Strand cDNA Synthesis Kit (Takara Bio, Shiga, Japan).
Gene-specific primers were used for quantitative real-timeTable 1 Primers of DR3, PDCD5, p53 and FasL for MSP








FasL(U) TTTAGGAGAATTAGTAGTTGGGGTPCR; the primers are shown in Table 2. Real-time PCR
was performed in the ABI 7500 sequence detection system
(Applied Biosystems) with a reaction mixture that con-
sisted of SYBR Green 2 × PCR Master Mix (Tiangen bio-
tech co., LTD., Beijing, China), cDNA template, forward
primer and reverse primer. Each real-time PCR was com-
posed by adding 16 μL of H2O, 1 μL of forward and 1 μL
of reverse primer (10 μM), 25 μL 2 × SuperReal PreMix,
5 μL 50 × ROX Reference Dye, 2 μL cDNA templates in a
total volume of 50 μL. The real-time PCR protocol con-
sisted of 1 cycle at 95°C for 15 min, 40 cycles at 95°C for
10 s, 60°C for 20 s and 72°C for 31 s. Data of real time-
PCR were analyzed using the ABI 7500 sequence detec-
tion system software and the amounts of DR3, PDCD5,
FasL, p53 and methyltransferases DNMT1, DNMT3a and
DNMT3b mRNA were normalized to β-actin using the
CT method.
Flow cytometric analysis
To detect protein expression of the DR3, PDCD5, FasL
and p53, CIA synovial cells were treated with or without
daphnetin (40 μg/mL) or 5-aza-dc (20 μM) for 72 h, col-
lected by trypsinization and washed twice with PBS.
After collection cells were stained with fluorescein iso-
thiocyanate (FITC)-labeled rabbit anti-rat DR3, PDCD5,
FasL and p53 (Wuhan Boster Biological Technology.,
LTD.). Cells were fixed and then analyzed by flow cy-
tometry. Data acquisition and analysis were performed
in a Becton Dickinson FACS Calibur flow cytometer
using Cell Quest software.
Apoptosis analysis by Annexin V/Propidium Iodide (PI)
flow cytometry assay
Apoptosis of CIA rat synovial cells was examined using a
FITC-labeled Annexin V/propidium iodide (PI) Apoptosis
Detection Kit (KeyGen Biotechology Co. Ltd., Nanjing,
China) according to the manufacture’s protocol. Cells
treated with or without Daphnetin (40 μg/mL) or 5-aza-dc
(20 μM) for 72 h were collected by trypsinization and
washed twice with PBS. The cells were resuspended in









Table 2 Primers of DR3, PDCD5, p53 and FasL for real-time PCR
Target gene Locus Sense sequence(5′-3′) Antisense sequence(5′-3′) Product size(bp)
DR3 NM_001137644.1 gctacgaacctacaacataccg acagtcccaagaaggaacgag 181
PDCD5 NM_001106247.1 acgaaagcagtggagaactacc ttcttttctgtctgttggctga 119
p53 NM_030989.3 gcccatccttaccatcatcac cacaaacacgaacctcaaagc 80
FasL NM_012908.1 ggtgctaatggaggagaagaag aaatggtcagcaacggtaagat 105
DNMT3a NM_001003958.1 gtgcttaccaatacgatgacga atccacacactccacacaaaag 122
DNMT3b NM_001003959.1 ggtaggagatggagatggtgaa atactgttgctgtttcgggttc 138
DNMT1 NM_053354.3 gtgtggtgtctgtgaggtctgt gtttcttcttcttcccttggtg 221
β-actin NM_001009180.2 tgacaggatgcagaaggaga tagagccaccaatccacaca 106
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30 min at room temperature. The labeled cells were ana-
lyzed by flow cytometry. Data acquisition and analysis
were performed in a Becton Dickinson FACS Calibur flow
cytometer using Cell Quest software.
Observation of CIA rats synovial cell ultrastructure by
SEM and TEM
SEM: CIA rat synovial cells were settled on Poly-l-
Lysine coated coverslips (12 mm) in a 24-well plate at a
density of 2 × 106 cells/mL, fixed with 6.25% glutaralde-
hyde in 50 mM phosphate buffer, pH 7.2, for 10 minutes
at room temperature, and subsequently incubated over-
night at 4°C. After washing with phosphate buffer, the
samples were dehydrated stepwise in acetone, critical-
point dried and sputtered with platin/palladium. Cells
were examined by SEM analysis, using a Zeiss DSM 962
scanning electron microscope(S-3000 N, Japan).
TEM: Cultures of CIA rat synovial cells were chemically
fixed in an aqueous solution of glutaraldehyde (2.5%) in
0.1 M sodium cacodylate buffer (pH 7.4) for two days at
4°C. Decalcification was achieved by treatment with 5% ni-
tric acid for seven days. The samples were rinsed for
24 hours, then post-fixed with a 1% osmium tetroxide so-
lution (in 0.1 M sodium cacodylate buffer, pH 7.4) over a
period of four hours at 4°C. The specimens were then
washed four times in isotonic sodium cacodylate buffer
(0.1 M; pH 7.4) and dehydrated through a graded series of
ethanol and ethyl carbinol. Thereafter, the specimens were
embedded in epoxy resin. Polymerization was performed
at 60°C over 48 hours. Thin sections were stained with ur-
anyl acetate and lead citrate and then examined by trans-
mission electron microscopy (Hitachi H-600, Japan).
Statistical analysis
All data represent at least three independent experiments
and were expressed as mean ± standard deviation (S.D.).
Parametric was evaluated by one-way ANOVA followed by
LSD post hoc multiple comparison test. A T-test was used
to determine the significances of differences in multiplecomparisons. Values of P < 0.05 were considered statisti-
cally significant in all cases.
Results
Effect of daphnetin and 5-aza-dc on cell viability
MTT assay was used to evaluate the inhibitory effect of
daphnetin and 5-aza-dc on CIA rat synovial cells. As
shown in Figure 1, treatment with daphnetin and 5-aza-
dc both reduced cell growth of to CIA rat synovial cells
in significant dose-dependent and time-dependent fash-
ion. The data verify that daphnetin has similar inhibitory
effect, as comparing with 5-aza-dc, on the proliferation
of synovial cells in vitro.
Effect of daphnetin and 5-aza-dc on methylation of in CIA
rat synovial cells
Next, we detected DNA mathylation of proapoptotic
genes DR3, PDCD5, FasL and p53 in the synovial cells
after treatment of daphnetine and 5-aza-dc. MSP results
(Figure 2) showed that methylation primer and the de-
methylation primer amplification specific strips of the
proapoptotic genes DR3, PDCD5, FasL and p53 were all
out in the untreated CIA rat synovial cells. The methylated
band brightness of PDCD5, DR3, FasL and p53 was greatly
reduced and the corresponding demethylated band bright-
ness was improved after the treatment with daphnetin and
5-aza-dc. The combination group, compared to the con-
trol CIA, showed the greatest change in demethylation
status. The combination group showed no methylation
band of the PDCD5 gene, which indicates that PDCD5
was in a completely demethylated state. These data sug-
gest that daphnetin possess stronger capacity than 5-aza-
dc in term of inducing DNA demethylation of proapototic
genes in the joints of CIA rats.
Effect of daphnetin and 5-aza-dc on expression of DR3,
PDCD5, FasL, p53 and methyltransferases DNMT1,
DNMT3a and DNMT3b in CIA rat synovial cells
Real-time quantitative PCR was used to indicated the effect
of daphnetin and 5-aza-dc on expression of DR3, PDCD5,
Figure 1 Effect of daphnetin and 5-aza-dc on the viability of CIA rat synovial cells. MTT assay was used to detect cell viability after
treatment with varying concentrations of daphnetin (A) or 5-aza-dc (B) for 36 h, 48 h, 60 h and 72 h. The data shown are the mean from three
parallel experiments.
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DNMT3b in CIA rat synovial cells. The results showed that
DR3, PDCD5, FasL and p53 mRNA were expressed at sig-
nificantly higher levels in daphnetin and 5-aza-dc treated
cells compared to control (Figure 3A). DR3, PDCD5 and
p53 mRNA were expressed at significantly higher levels in
daphnetin than in 5-aza-dc treated cells. At the same time,
DR3, PDCD5, FasL and p53 mRNA levels in the combinedtreatment were the highest of the four groups (Figure 3A).
However, DNMT1, DNMT3a and DNMT3b were
expressed at significantly lower levels in daphnetin and 5-
aza-dc treated cells compared to control (Figure 1B).
DNMT3a and DNMT3b mRNA were expressed at signifi-
cantly lower levels in daphnetin than in 5-aza-dc treated
cells. Lastly, DNMT1, DNMT3a and DNMT3b mRNA






M      U
5-aza-dc
M       U
Daphnetin
M       U
Combination
M       U
Figure 2 Methylating effect of daphnetin and 5-aza-dc on DR3, PDCD5, FasL and p53 in CIA rat synovial cells. Four experimental groups
consisting of untreated cell control, or treated with 5-aza-dc at 20 μM, daphnetin at 40 μg/mL, or combination of 5-aza-dc (20 μM) and daphnetin
(40 μg/mL). Cells were cultured, treated and harvested as described in Materials and Methods. Total DNA was extracted and used for MSP after
bisulphite modification. M: methylated amplification products, U: hypomethylated amplification products.
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capable of upregulating the expression of proapoptotic
gene (ie., DR3, PDCD5, FasL and p53 mRNA) though
degrading the methyltransferases DNMT1, DNMT3a
and DNMT3b.Effect of daphnetin on protein expression of DR3, PDCD5,
FasL and p53 in CIA rat synovial cells
Flow cytometry analysis was used to detect the effect of
daphnetin on protein expression of DR3, PDCD5, FasL
and p53 in CIA rat synovial cells showed that DR3,
PDCD5, FasL and p53 proteins were expressed at signifi-
cantly higher levels in daphnetin and 5-aza-dc treated
cells compared to control (Figure 4). DR3, PDCD5 and
p53 protein were expressed at significantly higher levels
in daphnetin than in 5-aza-dc. At the same time, DR3,
PDCD5, FasL and p53 protein in the combination were
the highest of the four groups. The data uncover the up-
regulated expression of proapototic gene DR3, PDCD5,
FasL and p53 in the joints of CIA mice after treatment
with daphnetin and 5-aza-dc.Possible involvement of apoptosis in daphnetin and
5-aza-dc-induced cell death
Annexin V/PI staining was applied to detect apoptotic cells
after daphnetin and 5-aza-dc treatment. Figure 5 showed
that treatment with daphnetin and 5-aza-dc significantly in-
duced apoptosis in CIA rat synovial cells. The combination
induced the highest amount of necrosis. These data sug-
gested that apoptosis is involved in suppression of synovial
cell proliferation in CIA rats after treatment with daphnetin
and 5-aza-dc.Effect of daphnetin and 5-aza-dc treatment on the structure
of CIA rat synovial cells
Scanning electron microscopy and transmission electron
microscopy were used to detecte the effect of daphnetin
and 5-aza-dc treatment on the structure of CIA rat syn-
ovial cells. The scanning electron microscopy showed that
the CIA rat synovial cells had round or oval shape and
their surface had fine microvilli hooks; the cells were
slightly deformed in the 5-aza-dc group, including a reduc-
tion in the surface microvilli compared to the control
group; meanwhile the cells in the daphnetin group had a
serious deformation and the cell surface microvilli hooks
disappeared and were replaced with small fingerlike projec-
tions; the synovial cells in the combination group displayed
extreme deformation, a smooth surface and a seriously
burst surface (Figure 6A).
Transmission electron microscopy showed visible sur-
face villi, clear nuclear membrane structure and pro-
minent nucleoli in the untreated CIA rat synovial cells
(Figure 6B). The nuclear pleomorphism showed that
cytoplasm organelles were well developed; the 5-aza-dc
group cells displayed a reduction in size, irregular form,
disappeared surface microvilli, a clear double layer, pyk-
notic nuclear chromatin complexed together within the
cytoplasm of a few rough endoplasmic reticulum, in-
creased number of lysosomes, developed free ribosomes
and mitochondrial swelling and empty bubble degener-
ation, which all demonstrate apoptotic changes; the syn-
ovial cells in the daphnetin treatment group had further
apoptotic developments compared with the 5-aza-dc
group; the nuclear membrane obviously disappeared
and apoptotic bodies formed in the synovial cells of
the combination group. Taken together, the electronic
microscopic scans further verify the alternations of
Figure 3 Effect of daphnetin and 5-aza-dc on expression of DR3, PDCD5, FasL, p53 (A) and DNMT1, DNMT3a, DNMT3b (B) in CIA rat
synovial cells. Four experimental groups consisting of untreated cell control, or treated with 5-aza-dc at 20 μM, daphnetin at 40 μg/mL, or
combination of 5-aza-dc (20 μM) and daphnetin (40 μg/mL). Cells were cultured, treated and harvested as described in Matreials and Methods.
Total RNA was extracted and cDNA was synthesized. After reverse transcription, cDNA was used for real time-PCR. Relative quantification of gene
expression was performed by the 2-ΔΔCt method. The results show the mean ± S.D. of six independent experiments.▲P < 0.05 compared with
control, ●P < 0.05 compared with 5-aza-dc,☆P > 0.05 compared with 5-aza-dc, ★P > 0.05 compared with daphnetin, *P < 0.05 compared
with daphnetin.
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Discussion
Rheumatoid arthritis joint synovial cells have completely
transformed cell characteristics, which may be due to the
inflammation environment [19]. The modification of mam-
malian genomic DNA includes the methylation at the 5th
position of the cytosine (C) residue within cytosine-guaninedinucleotides (CpGs), resulting in the formation of 5-
methyl-cytosine (5mC). There are three kinds of mecha-
nisms that can inactivate genes, and in some cases
methylation is the only active mechanism. Fortunately,
DNA methylation is reversible and this feature promoted
the development of DNA demethylation drugs such as 5-
aza-dc, a DNA methyltransferase inhibitor that can specif-
ically inhibit the activity of methyltransferase, decrease the
level of DNA methylation and inhibit the growth of cells
Figure 4 Effect of daphnetin on DR3, PDCD5, FasL and p53 protein expression in CIA rats synovial cells. Cells were cultured, treated and
harvested as described Materials and Methods. Four experimental groups consisting of untreated cell control, 5-aza-dc at 20 μM, daphnetin at 40 μg/mL,
or combination of 5-aza-dc (20 μM) and daphnetin (40 μg/mL). The results show the mean ± S.D. of six independent experiments.▲P < 0.05 compared
with control, ●P < 0.05 compared with 5-aza-dc, ★P > 0.05 compared with 5-aza-dc, *P < 0.05 compared with daphnetin.
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contributes to the chronicity of RA and could be respon-
sible for the limitation of current therapies [21]. At the
same time Meinecke I discovered the role of RA synovial
fibroblasts (RASFs) in the initiation and progression of
joint destruction in RA [22]. Therefore, the role of the
methylation status of DNA is an important factor in RAFigure 5 Cell apoptosis/necrosis as measured by Annexin V/PI stainin
at 20 μM, daphnetin at 40 μg/mL, or combination of 5-aza-dc (20 μM) and da
staining and analyzed by flow cytometry. The results show the mean ± S.D. .o
●P < 0.05 compared with 5-aza-dc,☆P > 0.05 compared with 5-aza-dc, *P < 0pathogenesis, however, currently there are no relevant re-
ports about the methylation status of proapoptotic genes
in CIA rat synovial cells.
Death receptor 3 (DR3) participates in the apoptosis sig-
nal path and is often the target of gene silence. Takami N
found that the CpG islands in the DR3 gene promoter were
specifically methylated to down-modulate the expression ofg. Four experimental groups consisting of untreated cell control, 5-aza-dc
phnetin (40 μg/mL) for 72 h. Cells were then processed for Annexin V/PI
f six independent experiments.▲P < 0.05 compared with control,
.05 compared with daphnetin.
control 5-aza-dc Daphnetin combination
A
B
Figure 6 Effect of daphnetin and 5-aza-dc on the structure of CIA rat synovial cells. Four experimental groups consisted of untreated cell
control, 5-aza-dc at 20 μM, daphnetin at 40 μg/mL, or combination of 5-aza-dc (20 μM) and daphnetin(40 μg/mL). (A): SEM; (B): TEM.
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vide resistance to apoptosis [18]. Programmed death gene 5
(PDCD5) has an effect of promoting tumor cell apoptosis
and inhibiting tumor cell proliferation. A study found that
PDCD5 may serve as a therapeutic target to enhance sensi-
tivity to antirheumatic drug-induced apoptosis in RA [23].
FasL belongs to TNF/LT super family members. The com-
bination of FasL and Fas can lead to Fas-induced cells
apoptosis. Experiments have proved that Fas mRNA ex-
pression is higher in the RA synovium culture cell in vitro,
suggesting that it may be in a state of activation, yet FasL
mRNA expression was not found [24] and the reason be-
hind the lack of FasL expression is not clear. p53 is classic
tumor suppressor gene and plays an important role in cell
proliferation, DNA repair and apoptosis. It was found that
p53 in RASFs can adjust the function of Th1 and Th17 cells,
and it plays an important role in the pathogenesis of RA
[25]. There have many reports about the methylation status
of p53 in other diseases [26-28], but there has not been any
related research in RA. Our results indicated that DR3,
PDCD5, FasL and p53 in CIA rat synovial cells were all in a
state of hypermethylation and treatment with daphnetin,
lowered the states of methylation in these genes. At the
same time, the expression of DR3, PDCD5, FasL and p53
in the daphnetin group was significantly increased. More-
over, daphnetin worked better than the demethylation re-
agent 5-aza-dc. So we proposed that daphnetin decreases
the expression of methyltransferases which results in the
demethylation of proapoptotic genes such as DR3, PDCD5,
FasL and p53, therefore enhancing proapoptotic gene ex-
pression and the rate of apoptosis.The methylation of mammalian genomic DNA is cata-
lyzed by DNA methyltransferases (DNMTs), which play a
special role in the initiation of chromatin remodeling and
gene expression regulation. The mammalian DNMTs are
DNMT1, DNMT3A and DNMT3B. DNMT1 activity is
crucial for the maintenance of DNA methylation, whereas
DNMT3A and DNMT3B are de novo methyltransferases
[29]. We adopted RT-PCR to detect the mRNA levels of
DNMT1, DNMT3a and DNMT3b, the results showed
that either daphnetin or 5-aza-dc can significantly reduce
the mRNA levels of DNMT1, DNMT3a and DNMT3b in
CIA rat synovial cells.
RA is a chronic autoimmune disease with characteristics
of synovial inflammation. RASFs have been assigned a key
role in the pathogenesis of RA and have been described as
appearing transformed, tumor-like, or simply activated
[30]. The mechanisms leading to hyperplastic synovitis are
not fully understood, although paucity of apoptosis may
contribute to the pathogenesis of RA. Apoptosis of RASFs
may reduce secretion of a variety of inflammatory cell fac-
tors, which can decrease the intra-articular inflammation.
So understanding how RASFs develop hyperplasia may be
of great significance for clarifying the pathogenesis of RA
and finding a new therapeutic target. This study used
Annexin V/PI flow cytometry staining to observe the
apoptotic condition of CIA rat synovial cells in each
experimental group and found that daphnetin could sig-
nificantly increase the apoptotic rate of CIA rat synovial
cells. In addition, scanning and transmission electron mi-
croscopy observed the structural cell changes and found
that CIA rat joint synovial cells in the daphnetin group
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All the results demonstrate that daphnetin has a pro-
nounced effect on promoting CIA rat synovial cell apop-
tosis and increases the rate of apoptosis.
Conclusion
Our findings demonstrate one of the molecular mecha-
nisms behind daphnetin’s ability to promote CIA rat
synovial cell apoptosis, which was through the inhibition
of DNA methyltransferases DNMT1, DNMT3a and
DNMT3b mRNA expression. Daphnetin reduces methy-
lation and subsequently increase the expression of proa-
poptotic genes such as DR3, PDCD5, FasL and p53, thus
promoting the apoptosis of the CIA rat synovial cells.
This study provides a deeper insight into the develop-
ment of daphnetin as a treatment of RA.
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